NasdaqCM - Nasdaq Real Time Price USD
Celldex Therapeutics, Inc. (CLDX)
33.62 +0.64 (+1.93%)
As of 3:41:00 PM EDT. Market Open.
Trade CLDX on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreChart Range Bar
Loading chart for CLDX
- Previous Close
32.98 - Open
32.94 - Bid 29.00 x 100
- Ask 38.26 x 100
- Day's Range
32.62 - 34.13 - 52 Week Range
19.52 - 35.79 - Volume
808,030 - Avg. Volume
946,064 - Market Cap (intraday)
2.639B - Beta (5Y Monthly) 0.93
- PE Ratio (TTM)
-- - EPS (TTM)
-4.27 - Earnings Date (est.) Aug 6, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
57.53
Recent News
View More
![[Latest] Global Cholera Vaccine Market Size/Share Worth USD 649 Million by 2035 at a 7.6 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](https://s.yimg.com/uu/api/res/1.2/JDc8Q43tjkZAOscxTVa7kA--~B/Zmk9c3RyaW07aD02Mzt3PTg0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/0bec09301614ea6a3ee415db83086891.cf.webp)
Performance Overview
Trailing total returns as of 6/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
CLDX
23.77%
S&P 500 (^GSPC)
7.31%
1-Year Return
CLDX
55.27%
S&P 500 (^GSPC)
20.58%
3-Year Return
CLDX
5.28%
S&P 500 (^GSPC)
68.94%
5-Year Return
CLDX
5.08%
S&P 500 (^GSPC)
72.18%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 6/23/2026
Market Cap
2.59B
Enterprise Value
2.14B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.53k
Price/Book (mrq)
5.67
Enterprise Value/Revenue
2.47k
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-30.89%
Return on Equity (ttm)
-48.94%
Revenue (ttm)
865k
Net Income Avi to Common (ttm)
-283.65M
Diluted EPS (ttm)
-4.27
Balance Sheet and Cash Flow
Total Cash (mrq)
451.46M
Total Debt/Equity (mrq)
0.42%
Levered Free Cash Flow (ttm)
-126.27M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.